These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21941437)

  • 1. Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency.
    Häberle J
    Ther Clin Risk Manag; 2011; 7():327-32. PubMed ID: 21941437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyperammonemia.
    Häberle J
    Expert Rev Endocrinol Metab; 2012 May; 7(3):263-271. PubMed ID: 30780843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatment.
    Ah Mew N; Caldovic L
    Appl Clin Genet; 2011; 4():127-35. PubMed ID: 23776373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature.
    Kenneson A; Singh RH
    Orphanet J Rare Dis; 2020 Oct; 15(1):279. PubMed ID: 33036647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene delivery corrects N-acetylglutamate synthase deficiency and enables insights in the physiological impact of L-arginine activation of N-acetylglutamate synthase.
    Sonaimuthu P; Senkevitch E; Haskins N; Uapinyoying P; McNutt M; Morizono H; Tuchman M; Caldovic L
    Sci Rep; 2021 Feb; 11(1):3580. PubMed ID: 33574402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of Carbamylglutamate impacts the nutritional management of patients with N-Acetylglutamate synthase deficiency.
    Singh RH; Bourdages MH; Kurtz A; MacLoed E; Norman C; Ratko S; van Calcar SC; Kenneson A
    Orphanet J Rare Dis; 2024 Apr; 19(1):168. PubMed ID: 38637895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylglutamate synthase deficiency: Novel mutation associated with neonatal presentation and literature review of molecular and phenotypic spectra.
    Al Kaabi EH; El-Hattab AW
    Mol Genet Metab Rep; 2016 Sep; 8():94-8. PubMed ID: 27570737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favourable long-term outcome after immediate treatment of neonatal hyperammonemia due to N-acetylglutamate synthase deficiency.
    Gessler P; Buchal P; Schwenk HU; Wermuth B
    Eur J Pediatr; 2010 Feb; 169(2):197-9. PubMed ID: 19533169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding sequence variants define a novel regulatory element in the first intron of the N-acetylglutamate synthase gene.
    Häberle J; Moore MB; Haskins N; Rüfenacht V; Rokicki D; Rubio-Gozalbo E; Tuchman M; Longo N; Yandell M; Andrews A; AhMew N; Caldovic L
    Hum Mutat; 2021 Dec; 42(12):1624-1636. PubMed ID: 34510628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel UPLC-MS/MS based method to determine the activity of N-acetylglutamate synthase in liver tissue.
    Dercksen M; Duran M; IJlst L; Kulik W; Ruiter JP; van Cruchten A; Tuchman M; Wanders RJ
    Mol Genet Metab; 2016 Dec; 119(4):307-310. PubMed ID: 27771289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Null mutations in the N-acetylglutamate synthase gene associated with acute neonatal disease and hyperammonemia.
    Caldovic L; Morizono H; Panglao MG; Cheng SF; Packman S; Tuchman M
    Hum Genet; 2003 Apr; 112(4):364-8. PubMed ID: 12594532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial N-acetyl glutamate synthase deficiency presenting as postpartum hyperammonemia: Diagnosis and subsequent pregnancy management.
    Abou Haidar L; Pachnis P; Gotway GK; Ni M; DeBerardinis RJ; McNutt MC
    JIMD Rep; 2023 Nov; 64(6):403-409. PubMed ID: 37927481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare urea cycle disorder in a neonate: N-acetylglutamate synthetase deficiency.
    Olgac A; Kasapkara ÇS; Kilic M; Emine Derinkuyu B; Azapagasi E; Kesici S; Biberoğlu G; Ozyazici A; Karaca M; Haberle J
    Arch Argent Pediatr; 2020 Dec; 118(6):e545-e548. PubMed ID: 33231058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel biochemically salvageable animal model of hyperammonemia devoid of N-acetylglutamate synthase.
    Senkevitch E; Cabrera-Luque J; Morizono H; Caldovic L; Tuchman M
    Mol Genet Metab; 2012 Jun; 106(2):160-8. PubMed ID: 22503289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Acetylglutamate Synthase Deficiency Due to a Recurrent Sequence Variant in the N-acetylglutamate Synthase Enhancer Region.
    Williams M; Burlina A; Rubert L; Polo G; Ruijter GJG; van den Born M; Rüfenacht V; Haskins N; van Zutven LJCM; Tuchman M; Saris JJ; Häberle J; Caldovic L
    Sci Rep; 2018 Oct; 8(1):15436. PubMed ID: 30337552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of pure recombinant human enzymes to assess the disease-causing potential of missense mutations in urea cycle disorders, applied to N-acetylglutamate synthase deficiency.
    Gougeard N; Sancho-Vaello E; Fernández-Murga ML; Martínez-Sinisterra B; Loukili-Hassani B; Häberle J; Marco-Marín C; Rubio V
    J Inherit Metab Dis; 2024 Nov; 47(6):1194-1212. PubMed ID: 38740568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid.
    Lazier J; Lupichuk SM; Sosova I; Khan AA
    Curr Oncol; 2014 Oct; 21(5):e736-9. PubMed ID: 25302046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in the treatment of hyperammonemia: emerging use of carglumic acid.
    Daniotti M; la Marca G; Fiorini P; Filippi L
    Int J Gen Med; 2011 Jan; 4():21-8. PubMed ID: 21403788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent encephalopathy: NAGS (N-acetylglutamate synthase) deficiency in adults.
    Cartagena A; Prasad AN; Rupar CA; Strong M; Tuchman M; Ah Mew N; Prasad C
    Can J Neurol Sci; 2013 Jan; 40(1):3-9. PubMed ID: 23250120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylglutamate synthase deficiency and the treatment of hyperammonemic encephalopathy.
    Elpeleg O; Shaag A; Ben-Shalom E; Schmid T; Bachmann C
    Ann Neurol; 2002 Dec; 52(6):845-9. PubMed ID: 12447942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.